TFX•November 13, 2026 at 8:09 PM UTCHealth Care Equipment & Services

Teleflex Raises 2026 EPS Guidance as Margin Expansion Accelerates

Read source article

What happened

Teleflex reported Q3 2026 adjusted gross margin of 66.8%, well above prior levels, prompting management to raise full-year adjusted EPS guidance to $7.50–$7.75, explicitly framing this as a floor rather than a midpoint. The company is executing its portfolio overhaul with cost cuts, deleveraging, and buybacks now expected to drive earnings growth more than top-line expansion. Freesolve's U.S. expansion and Ezplaz's $200M+ market opportunity offer additional upside optionality. The market had been pricing in a prolonged transition, but the latest results show the company is emerging from the earnings trough faster than previously modeled. This new information validates the core thesis that the market was overly focused on transition noise rather than the underlying business strength.

Implication

Investors should focus on capital deployment pace and continued margin expansion; if Freesolve and Ezplaz gain traction, the bull case of $155+ becomes achievable. The key risk remains divestiture timing, but the improved earnings trajectory provides a stronger cushion.

Thesis delta

The WAIT rating was based on uncertainty around divestiture timing and stranded costs. The Q3 2026 results and raised EPS guidance significantly de-risk the near-term earnings outlook, shifting the balance toward a more constructive view. While capital return execution still matters, the underlying business is proving more resilient than expected, justifying a potential upgrade to BUY if the stock price remains modest.

Confidence

High